Disclosure under Reg. 74(5) of SEBI (DP), Regulations, 2018.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
ANG Lifesciences India has submitted a routine compliance certificate to BSE under Regulation 74(5) of SEBI's Depositories and Participants Regulations. The certificate was issued by Bigshare Services Private Limited, the company's Registrar and Share Transfer Agent (RTA). It confirms that all physical share certificates received for dematerialisation between 1 October and 31 December 2025 were processed, verified, mutilated and cancelled, with the depository's name substituted as the registered owner in the company's records within the 15-day timeline. No new equity issuance, transfer or corporate action is involved — this is purely a quarterly procedural confirmation required by the regulator.
No impact on shareholders or stock price. This is a standard recurring filing required from every listed company; investors can ignore it for investment decisions.